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Abstract
Purpose: We assessed the impact of staff, clinic, and community interventions on male and 
female family planning client visit volume and sexually transmitted infection testing at a multisite 
community-based health care agency.
Methods: Staff training, clinic environmental changes, in-reach/outreach, and efficiency 
assessments were implemented in two Family Health Center (San Diego, CA) family planning 
clinics during 2010–2012; five Family Health Center family planning programs were identified as 
comparison clinics. Client visit records were compared between preintervention (2007–2009) and 
postintervention (2010–2012) for both sets of clinics.
Results: Of 7,826 male client visits during the time before intervention, most were for clients 
who were aged <30 years (50%), Hispanic (64%), and uninsured (81%). From preintervention to 
postintervention, intervention clinics significantly increased the number of male visits (4,004 to 
8,385; Δ = +109%); for comparison clinics, male visits increased modestly (3,822 to 4,500; Δ = 
+18%). The proportion of male clinic visits where chlamydia testing was performed increased in 
intervention clinics (35% to 42%; p < .001) but decreased in comparison clinics (37% to 33%; p 
< .001). Subgroup analyses conducted among adolescent and young adult males yielded similar 
findings for male client volume and chlamydia testing. The number of female visits declined 
nearly 40% in both comparison (21,800 to 13,202; −39%) and intervention clinics (30,830 to 
19,971; −35%) between preintervention and postintervention periods.
Conclusions: Multilevel interventions designed to increase male client volume and sexually 
transmitted infection testing services in family planning clinics succeeded without affecting female 
client volume or services.
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Family planning has been named one of the 10 greatest public health achievements of the 
20th century [1]. The federal Title X national family planning program, established by the 
Public Health Service Act of 1970 [2], is the only grant program dedicated solely to 
providing individuals with comprehensive family planning and related preventive 
reproductive health services [3]. The program has historically filled a need for reproductive 
health and contraceptive services for low-income and uninsured individuals and served 
primarily females. Over the last 40 years, males have comprised a small but increasing 
proportion of clients visiting federally funded family planning clinics.
In the mid-1990s reproductive health visits by male clients began to increase, as almost all 
publicly funded family planning clinics provided services to males, including testing and 
treatment for sexually transmitted infections (STIs) and reproductive health counseling [4]. 
In addition, for the past 15 years, the Department of Health and Human Services Office of 
Population Affairs, the federal agency managing Title X, has funded initiatives for 
improving family planning information, education, and clinical services targeting males. 
These programs have been successful, as the proportion of family planning visits by males 
more than quadrupled from 2% to 9% between 2002 and 2014 [5,6]. Often when males have 
accessed care, however, their reproductive health services have been neither comprehensive 
nor integrated into their broader health care needs [7]. Studies have sought to identify clinic-
based interventions to improve male client reproductive health knowledge and increase safer 
sex behaviors [8,9].
Targeted STI screening of higher risk males, such as those seeking reproductive health 
services, enrolled in job training programs, or who are socially disadvantaged, may be an 
effective public health prevention strategy [10–12]. For example, many clinic-based STI 
testing programs addressing Chlamydia trachomatis have focused on adolescent and young 
adult women and their male sex partners [13]. In these programs, the rates of genital 
chlamydial infections among men are moderately high, particularly in young adult and racial 
minority males [14]. A broad set of interventions has been identified that show promise for 
improving the mix of family planning clinic users by sex and provision of STI testing 
[15,16].
Based on prior research, we implemented a 5-year field intervention study designed to 
increase the number of males seeking services at family planning clinics. Our objective was 
to assess the impact of staff, clinic, and community-level interventions on male and female 
family planning clinic volume for selected clinics that did and did not implement project 
interventions. We evaluated whether interventions increased visits by males to family 
planning clinics, increased provision of chlamydia testing services of male clients, and 
affected the census of female clients and receipt of chlamydia testing services by adolescent 
and young adult women served at those clinics.
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Methods
Study design
The Department of Health and Human Services/Office of Population Affairs funded five 
family planning grantees in 2009 to expand male reproductive health services via staff and 
clinic innovation interventions within both the clinics and the surrounding community. As a 
project grantee, Family Health Centers (FHCs) of San Diego, CA, included 15 clinics that 
provided family planning, reproductive health, or STI-related services. Of these, we enrolled 
two family planning clinic programs as intervention sites and also identified five other FHC 
family planning programs with similar client populations and family planning service 
models to serve as comparison sites. Intervention sites were chosen in collaboration with 
FHC management and factored in medical director support and staff capacity to commit to 
training and intervention activities. Five interventions, described in the following section, 
were initiated beginning in 2010, at the two intervention clinics:
1. In-reach: Clinic staff members were trained on using in-reach strategies with 
their female clients by encouraging women to inform male partners, friends, and 
relatives about reproductive health services. Promotoras, middle-aged women 
who were well-respected community members, were used at one intervention 
site in a predominantly Hispanic community. These part-time volunteers 
approached males and couples in the clinic waiting room and at the building 
entrance to inform them about the availability of male reproductive health 
services. For males expressing interest, the promotoras arranged clinic 
appointments and shared contact information with the project coordinator, who 
proceeded to make reminder calls in advance of scheduled appointments. At the 
second intervention site, the clinic’s outreach worker provided community 
outreach and clinic in-reach. For the latter, the worker approached male clients in 
the waiting area. If interested, the worker would suggest having a further 
confidential conversation about STI services in a separate room, as needed.
2. Outreach: Clinic staff made presentations to community-based organizations and 
local health, social service, and correctional agencies about available male 
reproductive health services at FHC.
3. Clinic efficiency: Patient flow analyses were implemented to help program 
managers identify and resolve service bottlenecks for clients transitioning 
between clinic stations and to reduce wait times. Intervention sites did not 
receive additional resources to increase staff or program hours.
4. Staff training: Staff members were provided training on the “culture of men” and 
providing services to male clients. The training included gender differences in 
communication and decision-making, influences of socialization on male sexual 
health, and the possible impact of male stereotyping on services. Staff reviewed 
clinic visit components, including determining service needs, contraceptive 
options, medical history, sexual health assessment, sexually transmitted disease 
services, preventive health services, and risk counseling. Clinical staff also 
received skill-based training on conducting male genital exams, including 
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documentation of normal growth and development and other common genital 
findings.
5. Clinic environment: Staff assessed intervention sites’ physical settings to identify 
possible areas for improvements, for example, incorporating male-appropriate 
brochures and materials in waiting rooms and medical posters in exam rooms. 
Clinic intake forms, policies, and protocols were updated to better reflect male 
clients and their health care needs.
Data sources
For primary analyses, we accessed all 20,711 de-identified male family planning client clinic 
visit records from the administrative client information system for the seven participating 
clinics in FHC’s network (i.e., two interventions and five comparisons) from 2007 through 
2012. In addition, we accessed 85,803 de-identified clinic visit records for female clients 
aged 15–24 years from the same clinics for the same years. This age range selected for 
female clients represents a priority clinical population for prevention of both STIs and 
unintended pregnancies [17,18]. Two periods were compared between intervention and 
comparison clinics: (1) 2007–2009, before interventions were implemented and (2) 2010–
2012, during and after interventions were implemented (herein referred to as 
“preintervention” and “postintervention”) periods, respectively. Computerized visit records 
were extracted by agency information managers and routed to the coordinating center 
(Cardea Services, Seattle, WA) via secure and encrypted electronic file transfer. Measures 
included clinic identifier, visit calendar quarter and year (recoded as preintervention vs. 
postintervention period), and condition (comparison vs. intervention clinic); client 
demographic and visit characteristics (sex, age, and race/ethnicity, federal poverty level 
[Client federal poverty level is based on self-reported annual income that is then compared 
with the most recent HHS guidelines. Unemancipated minors who wish to receive services 
on a confidential basis must be considered according to their own resources.]), insurance 
status, and client visit status (new or continuing client [A new client visit was defined as an 
individual who had not been to any FHC clinic nor received any FHC health program 
services prior to that family planning visit; a continuing visit indicated that the individual 
had had one or more prior visits for any type of health service anywhere in the FHC system 
of clinics.]); chlamydia test performed; and chlamydia test results. We developed a joint 
race/ethnicity measure [19] where records identified as Hispanic ethnicity–regardless of 
race–were assigned to race/ethnicity’s Hispanic category.
Statistical analysis
Descriptive statistics were calculated for all measures. We compared male and female client 
volume by intervention status and period. STI service delivery, operationalized as chlamydia 
testing, was stratified by client demographics, visit characteristics, intervention status, and 
period. We used Pearson’s chi-squared test or Fisher’s exact tests to assess differences in 
proportions. Bivariate and multivariate log-binomial regression procedures were used to 
assess the relationship between chlamydia testing and client demographic and visit 
characteristics, intervention status, and time period [20,21]. Multivariate procedures were 
implemented separately for visit records within preintervention and postintervention periods. 
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Covariates (age, race/ethnicity, poverty, insurance coverage, and client visit status) for 
multivariate analyses were selected based on bivariate results. Prevalence ratios (PRs) and 
95% confidence intervals (CIs) were calculated to evaluate factors associated with 
chlamydia testing. A two-sided p value < .05 was considered statistically significant. We 
performed analyses using SPSS, version 19 (Chicago, IL) [22].
Human participant protection
Overall study procedures were approved by the Washington State Institutional Review Board 
and, locally, by the University of California, San Diego, Human Research Protections 
Program. The study was based on an analysis of de-identified data from the administrative 
and client information systems of the FHCs. Protocols for informed consent were not 
required.
Results
Baseline male visit characteristics
Of 7,826 reproductive health visits by males to family planning clinics operated by FHCs 
before intervention, total visit volume by males between comparison and intervention clinics 
was comparable (Table 1). Overall, most visits were by males who were adolescents or 
young adults (aged < 30 years), Hispanic, residing in households below 100% of the federal 
poverty level and lacking health insurance. Visits at intervention clinics relative to 
comparison clinics were less common among men aged < 20 years (5% vs. 18%) and those 
who were insured (12% vs. 27%). Rates of chlamydia testing were comparable between 
comparison and intervention (37% vs. 35%) clinics.
Condition differences between preintervention and postintervention periods
Male client visit characteristics.—From preintervention to postintervention, the overall 
number of visits by males attending FHC clinics, regardless of condition, increased 65%, 
from 7,826 to 12,885 (Table 2). The number of comparison clinic visits by males increased 
modestly from preintervention to postintervention (2007–2009[pre]: 3,822 visits; 2010–
2012[post]: 4,500 visits; Δ = +18%), while visits by males at intervention clinics more than 
doubled (pre: 4,004; post: 8,385; Δ = +109%; p < .001 for difference in percent increase 
between conditions). Among planned subgroup analyses, the number of visits by adolescents 
at comparison clinics decreased 11% between preintervention and postintervention periods 
(pre: 699; post: 625) but increased 145% at intervention clinics (pre: 192; post: 470; p < .
001). In addition, the number of visits by Hispanic males attending comparison clinics 
increased 8% (pre: 2,287; post: 2,471; Δ = +8%), while visits at intervention clinics more 
than doubled (pre: 2,605; post: 5,531; Δ = +112%; p < .001). For client status, the number of 
new client visits by males at comparison clinics decreased 17% (pre: 1,259; post: 1,051), 
while such visits at intervention clinics increased 62% (pre: 1,047; post: 1,697; p < .001). 
Finally, all male visit characteristics in Table 2 showed statistically significant condition 
(comparison vs. intervention clinic) differences on pre/post change in client volume.
Male chlamydia testing services.—At comparison clinics, the number of chlamydia 
tests performed among male clients increased modestly between preintervention and 
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postintervention periods (pre: 1,413 tests; post: 1,496 tests; Δ = +6%) while the number of 
such tests at intervention clinics more than doubled (pre: 1,392; post: 3,504; Δ = +152%; p 
< .001 for difference in percent increase between conditions) (Table 2). Besides changes in 
test volume, there were also condition and period differences in the percentage of visits 
where a chlamydia test was done (Table 3). At comparison clinics, the percentage of visits 
by males where chlamydia testing was performed decreased by 11% from preintervention to 
postintervention periods (37% to 33%, respectively; p < .001 for difference in percentage 
change between periods); conversely, the percentage of male visits with a chlamydia test at 
intervention clinics increased by 20% (pre: 35%; post: 42%; p < .001). Among adolescents 
aged < 20 years, at comparison clinics the percentage of visits that included a chlamydia test 
was stable from preintervention to postintervention (41% to 42%, respectively; p = .58); 
while the percentage of visits at intervention clinics where chlamydia testing was performed 
during adolescent male visits increased by 36% (pre: 33%; post: 45%; p = .004). Similar 
group differences were found for young adult male clients aged 20–29 years, that is, no 
change over time for the comparison clinics and a 16% increase in testing at intervention 
clinics (pre: 38%; post: 44%; p < .001).
These overall differences in chlamydia testing were also found in subanalyses limited to 
males at their initial clinic visit as newly enrolled FHC clients. At comparison clinics, the 
number of chlamydia tests performed among new clients decreased 17% between 
preintervention and postintervention periods while the number of such tests at intervention 
clinics increased 62% (p < .001). In terms of percentage differences, at comparison clinics 
the proportion of new male clients tested for chlamydia remained stable from 
preintervention to postintervention periods (47 to 44%, respectively; p = .149); the 
proportion tested for chlamydia among new clients’ initial visits at intervention clinics 
increased 25% (pre: 51%; post: 64%; p < .001; data not hown). In subgroup analyses of male 
clients aged < 30 years, the proportion of new male visits at comparison clinics where a 
chlamydia test was performed was stable (pre: 50%, post: 53%; p = .252), while at 
intervention clinics chlamydia testing among new male clients aged < 30 increased 21% 
(pre: 53%, post: 64%; p < .001; data not shown).
In multivariate analyses with preintervention records condition was not significantly related 
to the likelihood that a chlamydia test was provided during male visits (adjusted PR = .99; 
95% CI = .93–1.06; data not shown). In multivariate results for the period when innovations 
were implemented (2010–2012), relative to comparison clinics, intervention clinics showed 
significantly higher chlamydia testing rates at male family planning visits (33% vs. 42%; 
adjusted PR = 1.24; 95% CI = 1.18–1.30) (Table 4).
Impact of clinic interventions on female visit volume and services provided
Finally, we assessed the impact of male-centered interventions at FHC clinics on clinic visit 
volume and rate of chlamydia testing among female clients aged 15–24 years. Between the 
preintervention and postintervention periods, the number of family planning visits by female 
clients aged 15–24 years declined 39% at comparison clinics (pre: 21,800 visits; post: 
13,202 visits) and 35% at intervention clinics (pre: 30,830; post: 19,971). Beyond visit 
volume, at comparison clinics the likelihood of chlamydia testing among visits for new 
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female clients aged 15–24 years remained stable from preintervention to postintervention 
period (26% vs. 28%, respectively; p = .175 for difference in percent increase between 
periods) but increased significantly at intervention clinics between periods (pre: 18%; post: 
36%; p < .001).
Discussion
This study revealed that, relative to comparison family planning clinics in FHC’s network, 
the volume of male client visits increased significantly at FHC clinics where staff, program, 
and clinic environmental interventions specifically promoting male services were 
implemented. At intervention clinics, the increase was particularly large for adolescents and 
continuing clients who had a prior health care service history in this network of clinics.
Besides increasing male client volume, intervention clinics increased the provision of 
chlamydia testing for males, especially among adolescent and new clients. Male family 
planning clients attending intervention sites were 24% more likely to be tested for chlamydia 
when community, clinic, and staff innovations were implemented. This increased likelihood 
of STI testing at intervention sites was a function of two factors: the overall increase in male 
client attendance at clinics and clinicians expanding the proportion of their male clients 
where a chlamydia test was ordered.
Most importantly, given the long-standing commitment, these clinics have made under 
federal Title X funding to provide family planning services for women, interventions 
designed to increase the number of visits by males did not differentially affect the volume of 
visits or receipt of chlamydia testing by female clients. Thus, given the context that the 
overall number of visits by female clients attending Title X clinics have been markedly 
declining over the past decade [5], concerns that increasing delivery of services to male 
clients at family planning clinics would come at the expense of providing female clients full 
access to reproductive health care were unfounded.
The project focused on increasing access to family planning clinics by males, and upon 
entering the system, to enhance STI testing and treatment, provide ongoing counseling about 
STI and pregnancy prevention, and meet general reproductive health needs. Recent research 
has highlighted the importance of identifying high-risk young men in need of STI services. 
Risk has been operationalized via individuals’ sexual network characteristics, for example, 
men with multiple concurrent sex partners [23], as well as broader service system 
characteristics, for example, adolescent males in juvenile detention facilities [10]. Although 
screening has resulted in identifying significant numbers of males requiring treatment, it has 
been challenging to link male screening to community-level STI morbidity among women 
[24].
Lessons learned and future research
Future research regarding the design and implementation of program innovations could build 
on four lessons learned from this study. First, routine administrative information systems are 
underutilized but highly cost-efficient sources of information that can be used to assess 
intervention effectiveness. These systems are also limited to existing client demographics 
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and service outputs, such as the number and type of STI tests performed. Having easily 
accessible, de-identified data on client demographics and receipt of clinical services will 
become increasingly important as health care systems shift from simply monitoring service 
delivery to evaluating the effectiveness of programs and interventions.
Second, future work could enhance the measures available in administrative information 
systems for monitoring client health and informing program direction. Where feasible, the 
focus on client characteristics and services could be further expanded to include client 
sexual history and recent sexual behaviors (e.g., number of recent sex partners, condom and 
contraceptive use).
Third, although the intervention was not designed to address female chlamydia screening, 
we observed that chlamydia testing increased significantly during adolescent and young 
adult female family planning visits within the two clinics where interventions emphasized 
STI testing for male clients. While this shift cannot be directly attributed to innovations 
focused on male client service delivery, this unexpected finding reinforces the need to 
monitor how changes in male family planning service delivery might impact the volume of 
female clients and their access to STI services.
Fourth, based on our assessment of project implementation, future efforts to expand male 
family planning clients and STI services must recognize that implementing systemic 
changes require commitment from management and front line personnel, ongoing 
communication, and significant shifts in agency culture to address challenges. Potential 
challenges range from staff concerns about how female clients would view the increased 
presence of male clients on-site to the need for additional training on male genital exams. 
These efforts are part of a broad and empirically based effort to improve reproductive health 
services for male and female clients across current and potential providers of family 
planning services in the United States (Program managers interested in replicating our 
study’s clinic assessment and intervention activities to increase male family planning clients 
can find the project toolkit at: http://www.cardeaservices.org/resourcecenter/getting-ready-
for-male-reproductive-health-services.) [25].
Limitations and strengths
Our findings are subject to at least five limitations. First, we relied on the agency’s existing 
administrative information system, which lacked key measures related to use of family 
planning services such as sexual orientation, clinical exam findings, or sexual risk behaviors. 
In addition, data were collected at the visit level and could not be aggregated to client 
summaries; thus, we were unable to account for the effect of repeat visits by clients. Second, 
we did not measure the amount or intensity of male-centered interventions–either at clinics 
where they were implemented or at comparison clinics. Third, the nonrandomized 
observational design limits our ability to conclusively attribute intervention effects to project 
interventions [26]. Fourth, we could not determine which of the intervention’s five 
components may have accounted for changes in male client volume or STI testing. Finally, 
our work was limited to a single set of family planning clinics in San Diego and may not be 
generalizable to other family planning clinics or the general population.
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Several strengths of the study design should be noted. First, the reliance on a single health 
care agency within a relatively small geographic area with common protocols and 
administrative information systems to identify intervention and comparison clinics 
strengthened the rigor of our approach. Second, we were able to utilize existing 
administrative information systems to efficiently assess client characteristics and services 
over an extended timeframe. Third, since our evaluation used de-identified administrative 
data, it involved neither active consent by clients nor the opportunity for nonparticipation, 
which reduced threats to external validity, as biases related to clients’ awareness of 
participating in a field study were avoided [27]. Fourth, the use of routinely collected 
information allowed us to assess the impact of study interventions on female family planning 
client volume and receipt of services post hoc, in addition to male services. Monitoring 
female clients’ receipt of STI services is also critical in the context of the mission of 
maintaining women’s access to reproductive health services.
Family planning clinics within San Diego’s FHCs implemented program and community 
innovations that showed significant increases in the frequency of male reproductive health 
client visits and STI testing, particularly among adolescent and young adult males. As 
important, these results did not adversely affect female family planning visit volume or 
receipt of chlamydia testing. For family planning programs, particularly those embedded in 
larger health care agencies, the tested interventions may be a promising approach to 
increasing male clinic attendance and STI testing. However, further research is needed to 
assess the efficacy of specific elements in our multiple-component intervention.
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IMPLICATIONS AND CONTRIBUTION
Family planning clinics within San Diego’s Family Health Centers implemented program 
and community interventions that showed significant increases in the frequency of male 
reproductive health client visits and chlamydia testing. These effective innovations 
contribute to the practice literature on increasing clinical services to adolescent and 
young adult males.
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Table 1
Comparison of baseline male client characteristics between intervention and comparison clinics; Family 
Health Centers’ family planning clinics, San Diego, CA
Characteristic All Comparison clinics Intervention clinics
N (%) N (%) N (%)
Male visits, total 7,826 (100) 3,822 (100) 4,004 (100)
Age, years
 <20 891 (11) 699 (18) 192 (5)
 20–29 3,086 (39) 1,462 (38) 1,624 (41)
 30–39 1,949 (25) 811 (21) 1,138 (28)
 >39 1,900 (24) 850 (22) 1,050 (26)
Race/ethnicity
 Asian/Native Hawaiian and other Pacific Islander 175 (2) 139 (4) 36 (1)
 Black (non-Hispanic) 739 (10) 549 (15) 190 (5)
 Hispanic 4,892 (64) 2,287 (62) 2,605 (66)
 Multiple/other 137 (2) 81 (2) 56 (1)
 White (non-Hispanic) 1,695 (22) 652 (18) 1,043 (27)
Poverty status (% FPL)
 <100% FPL 6,207 (81) 3,116 (83) 3,091 (79)
 100%–125% FPL 689 (9) 295 (8) 394 (10)
 126%–150% FPL 318 (4) 136 (4) 182 (5)
 >150% FPL 495 (6) 231 (6) 264 (7)
Insurance
 Uninsured 6,340 (81) 2,806 (73) 3,534 (88)
 Insured, public/private 1,486 (19) 1,016 (27) 470 (12)
Client visit status
 New 2,306 (30) 1,259 (33) 1,047 (26)
 Continuing 5,520 (70) 2,563 (67) 2,957 (74)
Chlamydia test performed
 No 5,021 (64) 2,409 (63) 2,612 (65)
 Yes 2,805 (36) 1,413 (37) 1,392 (35)
FPL = federal poverty level.
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